ITMCTR1900002315尚未招募3 期
Research for synergistic effect with chemotherapy and mechanism of sequential regimen of invigorating spleen and kidney on advanced colon cancer
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- All
入选标准
- •(1) Patient with pathological diagnosis of colon cancer,tumor-node-metastasis(TNM)Stage IV colon cancer according to 8th edition of American Joint Committee on Cancer(AJCC)Staging Manual;
- •(2) Receiving or plan to start chemotherapy of XELOX or XELIRI;
- •(3) Aged between 18 to 80 years male and female and signed informed consent.
排除标准
- •1. History of previous malignancy other than adequately treated in situ carcinoma of the uterine cervix or basal or squamous cell carcinoma of the skin.
- •2. serious heart,liver or kidney dysfunction.
- •3. Those who cannot take the study drug orally because of bowel obstruction and/or require for peripheral vein nutrition;or malabsorption or diseases that affect the absorption;or active peptic ulcer disease.
- •4. Any unstable conditions or conditions that may endanger the safety of patients and their compliance with the study;
- •5. Patients who received any of the following treatments during a specified period prior to the research:
- •(1) received antibiotic treatment within 2 weeks;
- •(2) receiving intestinal flora regulator.
研究者
相似试验
进行中（未招募）
1 期
Study evaluating the effects of chemotherapy on incurable cancer of the esophagus or stomachEsophagogastric adenocarcinomaMedDRA version: 18.1Level: PTClassification code 10062878Term: Gastrooesophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-000127-24-DKRigshospitalet, Department of Oncology98
已完成
1 期
feasibility and efficacy of chemotherapy combined with zoledronic acid : phase I/II trial for adult T-cell leukemia/lymphoma (ZAAT study)JPRN-UMIN000007569Saga University, Faculty of Medicine, Devision of Hematology and Oncology21
已完成
4 期
A multicentre study using the chemotherapy combination of bi-monthly Xeloda and Eloxatin, with the addition of Avastin, in patients with advanced colorectal cancerCancerColorectal cancerISRCTN41540878Cancer Trials New Zealand (CTNZ)60
已完成
2 期
An exploratory study of chemotherapy enhancement effects of mefenamic acid and cilostazol in patients with locally advanced head & neck cancerlocally advanced head &neck cancerJPRN-UMIN000007871Chiba University Hospital120
尚未招募
Unknown
Side Effects in Chemotherapy PatientsCTRI/2023/10/059187Sumithra Devadiga